Andrew Reaume
Director Ejecutivo en Melior Discovery, Inc. .
Cargos activos de Andrew Reaume
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Melior Discovery, Inc.
Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | Director Ejecutivo | 01/01/2005 | - |
Fundador | 21/10/2009 | - | |
Presidente | 01/01/2005 | - | |
Melior Pharmaceuticals I, Inc.
Melior Pharmaceuticals I, Inc. Pharmaceuticals: MajorHealth Technology Melior Pharmaceuticals I, Inc. is a mid-stage biopharmaceutical company that develops therapies for diabetes, Parkinson's disease, sleep disorders, and nonalcoholic steatohepatitis (NASH). The private company is based in Exton, PA and was founded in 2008 by Andrew Reaume. The company's lead clinical stage candidates are in the areas of diabetes, NASH, Parkinson's disease, and sleep disorders. The company leverages the technology of their affiliate discovery for stage 1 research. Tolimidone is a Lyn kinase activator for treating type 2 diabetes and NASH. Mesocarb is a dopamine reuptake inhibitor for treating Parkinson's disease, sleep disorders, and other CNS conditions. | Presidente | 01/12/2008 | - |
Fundador | 01/12/2008 | - | |
Director Ejecutivo | 01/12/2008 | - |
Historial de carrera de Andrew Reaume
Antiguos cargos conocidos de Andrew Reaume.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | 01/01/1993 | 01/01/1999 |
ADHERA THERAPEUTICS, INC. | Director/Miembro de la Junta | 09/09/2021 | - |
PFIZER, INC. | Corporate Officer/Principal | - | - |
Formación de Andrew Reaume.
University of Pennsylvania | Masters Business Admin |
University of Connecticut | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 8 |
Operativa
Chief Executive Officer | 3 |
Founder | 3 |
President | 3 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
PFIZER, INC. | Health Technology |
ADHERA THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Melior Discovery, Inc.
Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | Commercial Services |
Melior Pharmaceuticals I, Inc.
Melior Pharmaceuticals I, Inc. Pharmaceuticals: MajorHealth Technology Melior Pharmaceuticals I, Inc. is a mid-stage biopharmaceutical company that develops therapies for diabetes, Parkinson's disease, sleep disorders, and nonalcoholic steatohepatitis (NASH). The private company is based in Exton, PA and was founded in 2008 by Andrew Reaume. The company's lead clinical stage candidates are in the areas of diabetes, NASH, Parkinson's disease, and sleep disorders. The company leverages the technology of their affiliate discovery for stage 1 research. Tolimidone is a Lyn kinase activator for treating type 2 diabetes and NASH. Mesocarb is a dopamine reuptake inhibitor for treating Parkinson's disease, sleep disorders, and other CNS conditions. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew Reaume
- Experiencia